Cargando…

RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)

RNA editing is an epitranscriptomic modification, leading to targeted changes in RNA transcripts. It is mediated by the action of ADAR (adenosine deaminases acting on double-stranded (ds) RNA and APOBEC (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like) deaminases and appears to play...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dafou, Dimitra, Kanata, Eirini, Pettas, Spyros, Bekas, Nikolaos, Dimitriadis, Athanasios, Kempapidou, Garyfalia, Lagoudaki, Roza, Theotokis, Paschalis, Touloumi, Olga, Delivanoglou, Nikoleta, Kesidou, Evangelia, Xanthopoulos, Konstantinos, Grigoriadis, Nikolaos, Papavasiliou, Fotini Nina, Sklaviadis, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688714/ https://www.ncbi.nlm.nih.gov/pubmed/36429012 http://dx.doi.org/10.3390/cells11223582

Ejemplares similares

A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations
por: Karagianni, Korina, et al.
Publicado: (2022)

Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis
por: Delivanoglou, Nickoleta, et al.
Publicado: (2020)

Application of antibody phage display to identify potential antigenic neural precursor cell proteins
por: Paspaltsis, Ioannis, et al.
Publicado: (2020)

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents
por: Kesidou, Evangelia, et al.
Publicado: (2017)

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2016)

Profiling Microglia through Single-Cell RNA Sequencing over the Course of Development, Aging, and Disease
por: Pettas, Spyros, et al.
Publicado: (2022)

Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases
por: Karagianni, Korina, et al.
Publicado: (2022)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
por: Lahiani-Cohen, Inbal, et al.
Publicado: (2020)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism
por: Xanthopoulos, Konstantinos, et al.
Publicado: (2013)

RNA editing alterations define manifestation of prion diseases
por: Kanata, Eirini, et al.
Publicado: (2019)

Autophagy and neurodegenerative disorders
por: Kesidou, Evangelia, et al.
Publicado: (2013)

Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning
por: Founta, Kyriaki, et al.
Publicado: (2023)

Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021)

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
por: Kanata, Eirini, et al.
Publicado: (2018)

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
por: Sragovich, Shlomo, et al.
Publicado: (2019)

Exercise intensity‐dependent immunomodulatory effects on encephalomyelitis
por: Fainstein, Nina, et al.
Publicado: (2019)

Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin
por: Dermitzakis, Iasonas, et al.
Publicado: (2022)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023)

Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
por: Damianidou, Olympia, et al.
Publicado: (2022)

Photo-Fenton and TiO(2) Photocatalytic Inactivation of Model Microorganisms under UV-A; Comparative Efficacy and Optimization
por: Kanata, Eirini, et al.
Publicado: (2023)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF
por: Bakhuraysah, Maha M., et al.
Publicado: (2021)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

“Ring-Like Mass” Surrounding the Cervix of a Primary Incisor. Report of a Challenging Case
por: Papageorgiou, Nikoleta, et al.
Publicado: (2021)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Immunization with Genetically Modified Trypanosomes Provides Protection against Transmissible Spongiform Encephalopathies
por: Triller, Gianna, et al.
Publicado: (2022)

Tauopathy in the young autistic brain: novel biomarker and therapeutic target
por: Grigg, Iris, et al.
Publicado: (2020)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

Perspectives of a scrapie resistance breeding scheme targeting Q211, S146 and K222 caprine PRNP alleles in Greek goats
por: Kanata, Eirini, et al.
Publicado: (2014)

Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors
por: Emamnejad, Rahimeh, et al.
Publicado: (2022)

The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
por: Ellen, Olivia, et al.
Publicado: (2023)

High-intensity interval training attenuates development of autoimmune encephalomyelitis solely by systemic immunomodulation
por: Goldberg, Yehuda, et al.
Publicado: (2023)

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
por: Sintila, Styliani-Aggeliki, et al.
Publicado: (2023)

N-Acetylcysteine Administration Attenuates Sensorimotor Impairments Following Neonatal Hypoxic-Ischemic Brain Injury in Rats
por: Kesidou, Evangelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uv6i8v8crg64jcsc9kp9t90fo9